Company profile: X-Chem
1.1 - Company Overview
Company description
- Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
Products and services
- Dynamic Drug Discovery (XD3): Integrated program combining ArtemisAI, DEL, and medicinal chemistry for transitioning from hit-to-lead and optimizing medicinal chemistry
- DEL Screening Services: High-throughput screening campaigns using DNA-encoded library (DEL) technology to identify small-molecule hits across diverse target classes
- ArtemisAI: Machine-learning-driven platform leveraging DEL screening data to predict new binders and expand chemical space for hit generation in small-molecule drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to X-Chem
Promium
HQ: United States
Website
- Description: Provider of environmental information management software for commercial and public sector organizations, offering LIMS solutions that enhance productivity and regulatory compliance through intuitive workflows, dynamic analytics, and robust data management; comprehensive environmental laboratory testing workflows; water analysis workflow support; and a cloud-based platform integrating data and workflows for efficient, compliant lab operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Promium company profile →
NoviSci
HQ: United States
Website
- Description: Provider of principled data science to improve the health and well-being of people.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NoviSci company profile →
EmpiraMed
HQ: United States
Website
- Description: Provider of registry patient-engagement software to generate real-world evidence for the life science industry, delivering a decentralized clinical study solution with automated study execution, novel patient recruitment, and mobile device independence. Products include PRO, PMR, and MED Portals, Decentralized Study Platform, Patient Incentive System, and Data Verification Model.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EmpiraMed company profile →
123Compliance
HQ: United States
Website
- Description: Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 123Compliance company profile →
PHT
HQ: United States
Website
- Description: Provider of Web-based clinical trial direct data capture and management technologies, including market-leading electronic patient reported outcome (ePRO) solutions used globally in clinical trials. Offers LogPad and StudyPad systems to improve data quality and the StudyWorks online portal providing study sponsors, monitors and sites with real-time access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHT company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for X-Chem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to X-Chem
2.2 - Growth funds investing in similar companies to X-Chem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for X-Chem
4.2 - Public trading comparable groups for X-Chem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →